Neuromodulation With Burst and Tonic Stimulation Decreases Opioid Consumption: A Post Hoc Analysis of the Success Using Neuromodulation With BURST (SUNBURST) Randomized Controlled Trial
ConclusionA device delivering tonic and burst SCS was associated with decreased opioid consumption after 12 months in patients with chronic trunk and/or limb pain. The proportion of patients reporting the highest opioid intake (>120 MME/day) decreased to a lower CDC dose category by 61.7%, carrying important implications for those at highest risk for opioid‐related substance use disorder, overdose, and death.
Source: Neuromodulation: Technology at the Neural Interface - Category: Biotechnology Authors: Ryan S. D'Souza,
Natalie Strand Tags: Clinical Research Source Type: research
More News: Back Pain | Biotechnology | Brain | Chronic Pain | Morphine | Neurology | Overdose | Pain | Study